2. Search Result
Search Result
Results for "

13-Dihydrocarminomycin

" in MedChemExpress (MCE) Product Catalog:

2

Inhibitors & Agonists

1

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-135176
    13-Dihydrocarminomycin

    		Endogenous Metabolite Cancer
    13-Dihydrocarminomycin (compound D788-12) is the major metabolite of the antitumor antibiotic Carminomycin (HY-B2171). 13-Dihydrocarminomycin has weak antitumor activity .
    13-Dihydrocarminomycin
  • HY-E71188
    13-Deoxydaunorubicin hydroxylase

    		Biochemical Assay Reagents Others
    13-Deoxydaunorubicin hydroxylase (EC 1.14.13.181) shows broad substrate specificity for structures based on an anthracycline aglycone, but have a strong preference for 4-methoxy anthracycline intermediates (13-Deoxydaunorubicin and 13-dihydrodaunorubicin) over their 4-hydroxy analogues (13-deoxycarminomycin and 13-dihydrocarminomycin) , as well as a preference for substrates hydroxylated at the C-13 rather than the C-14 position.
    13-Deoxydaunorubicin hydroxylase

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: